Adcetris 50mg (Brentuximab Vedotin) is the first approved CD-30 directed antibody drug conjugate. Adcetris contains the active substance brentuximab vedotin, an anti-cancer agent, which is made up of a monoclonal antibody linked to a substance intended to kill cancer cells.
Its use and indications
Adcetris® (Brentuximab Vedotin) injection for intravenous infusion is indicated for the treatment of:
- Hodgkins Lymphoma after failure of autologous stem cell transplant (ASCT)
- Hodgkins Lymphoma in patients who are not ASCT candidates after failure of at least 2 multiagent chemotherapy regimens
- Systemic anaplastic large cell lymphoma after failure of at least 1 multiagent chemotherapy regimen
Treatment related info
For treatment related information, please consult your treating Physician.
Adcetris powder for infusion 50 mg vial
Storage and handling
Store at 2°- 8° C, do not freeze.
How do we source the Drug?
Super Specialities Pharma -India will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Before you buy Adcetris, you need to familiarize yourself with possible side reactions:
On the part of the hematopoiesis system, neutropenia or thrombocytopenia is observed;
from the gastrointestinal tract: dyspeptic disorders, violation of the act of defecation;
from the musculoskeletal system: joint pain muscles, convulsions, stiffness of motion;
reactions of the type of allergic: skin itching, rash, alopecia;
from the central and peripheral nervous system: motor and sensory neuropathy, dimielinizing neuropathy.
Also, due to the decrease in overall immunity against the background of taking antitumor drugs, a secondary infection is often observed. The etiology of these diseases can be viral, bacterial or parasitic. As clinical trials show, most patients develop pneumonia, herpes zoster, catarrhal infections, various candidiasis. As preventive measures, patients should carefully follow the rules of personal hygiene, avoid a large crowd of people, and during the period of worsening seasonal diseases wear a mask.
When there are side effects, it is important to immediately report them to the treating oncologist. He must either cancel the drug, or adjust the dosage.